A Second Chance at Registration
Origent leverages advanced predictive analytics to rescue failed drug programs in ALS, Alzheimer’s, and other neurodegenerative diseases.
Managing Drug Development Risk through Better Foresight
Predicting patient-level dynamics allows researchers, drug developers, and investors better manage risks and reduce the costs of drug discovery.
Unparalleled ALS Predictive Modeling Capabilities
Origent's suite of predictive models accurately predict the progression of ALS and ALS symptoms.
Origent's clinical trial analysis tools help biotech firms conduct more cost efficient clinical trials and inform new experiments.
We help pharmaceutical companies identify the most promising prospects in their drug development pipeline earlier, to eliminate failing projects and better prioritize scarce resources.
Origent has a unique method for helping biotech investors evaluate clinical trial data during due diligence.